Comparison of chemosensitivity tests: Clonogenic assay versus MTT assay

Acta Medica Okayama

Volumn 56, Issue 3, 2002, Pages 129-134

  Kawada, Kazuhiko ^a   Yonei, Toshiro ^b   Ueoka, Hiroshi ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Takigawa, Nagio ^a   Harada, Mine ^c   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION OKAYAMA MEDICAL CENTER   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide (MTT) assay; Chemosensitivity test; Clonogenic assay

Indexed keywords

ANTINEOPLASTIC AGENT; COLORING AGENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; IC 50; LUNG TUMOR; METHODOLOGY;

ANTINEOPLASTIC AGENTS; COLORING AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0036594332     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Carmichael J: Chemosensitivity testing in lung cancer; in Lung Cancer, Pass HI, Mitchell JB, Johnson DH and Turrisi AT eds, Lippincott-Raven Publishers, Philadelphia (1996) pp161-167.
2. Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE and Mulder NH: In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data, Int J Cancer (1992) 51, 72-78.
3. Hamburger AW and Salmon SE: Primary bioassay of human tumor stem cells. Science (1977) 197, 461-463.
4. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS and Moon TE: Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med (1978) 298, 1321-1327.
5. Hiraki S, Ohnoshi T, Miyai M, Numata T, Kawahara S, Seto T, Tamura T, Ozawa S and Kimura I: Tumor stem cell assay for detecting metastases of human lung cancer. Acta Med Okayama (1983) 37, 141-146.
6. Yonei T, Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Moritaka T, Shibayama T, Tabata M, Segawa Y, Takigawa N and Kimura I: Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens. Acta Med Okayama (1993) 47, 233-241.
7. Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A and Boyd MR: Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay verous a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst (1990) 82, 1113-1118.
8. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst (1990) 82, 1107-1112.
9. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res (1987) 47, 936-942.
10. Matsushita A, Tabata M, Ueoka H, Kiura K, Shibayama T, Aoe K, Kohara H and Harada M: Establishment of a drug sensitivity panel using human lung cancer cell lines. Acta Med Okayama (1999) 53, 67-75.
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 65, 55-63.
12. Takigawa N, Ohnoshi T, Ueoka H, Kiura K and Kimura I: Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines. Acta Med Okayama (1992) 46, 249-256.
13. Campling BG, Pym J, Baker HM, Cole SP and Lam YM: Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer (1991) 63, 75-83.
14. Bepler G and O'Briant K: In vitro chemosensitivity testing of human non-small cell lung cancer cell lines. Anticancer Res (1998) 18, 3181-3185.
15. Mitsudomi T, Kaneko S, Tateishi M, Yano T, Ishida T, Kohnoe S, Maehara Y and Sugimachi K: Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test. Anticancer Res (1990) 10, 987-990.
16. Roper PR and Drewinko B: Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res (1976) 36, 2182-2188.
17. Hiraki S, Ohnoshi T, Numata T, Kishimoto N, Mori K, Yonei T, Yamashita H and Kimura I: Anticancer drug sensitivity by human tumor clonogenic assay. Acta Med Okayama (1986) 40, 265-269.
18. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A and Boyd MR: Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production. Cancer Res (1991) 51, 2515-2520.
19. Perez RP, Godwin AK, Handel LM and Hamilton TC: A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur J Cancer (1993) 3, 395-399.
20. Shimoyama M: Cytocidal action of anticancer antigens: Evaluation of the sensitivity of cultured animal and human cancer cells. Bibl Haematol (1975) 40, 711-722.